-+ 0.00%
-+ 0.00%
-+ 0.00%

Chaoju Ophthalmology (02219) subsidiary subscribes to a $16 million structured deposit product

Zhitongcaijing·07/23/2026 10:41:05
Listen to the news

According to Zhitong Finance App, Chaoju Ophthalmology (02219) announced that on July 23, 2026, Chaoju Eye Care (Hong Kong) Co., Ltd. (Chaoju Hong Kong, an indirect wholly-owned subsidiary of the Company) has further subscribed to structured deposit products with a total principal amount of 16 million US dollars provided by JPMorgan Chase Bank.

The subscription was funded by the Group's surplus cash rather than proceeds from global sales.